Skip to main content
. 2017 Jan 20;151(6):1320–1328. doi: 10.1016/j.chest.2017.01.019

Table 5.

Median Survival Estimates for Patients With CF and FEV1 < 30% Predicted, Stratified by Covariates of Interest

Variable Median survival (95% CI) P Value for Log-Rank Test
Female sex, y 5.1 (4.6-5.8) < .001
Male sex, y 7.2 (6.7-8.0)
BMI ≤ 18, y 4.2 (3.7-4.5) < .001
BMI > 18, y 7.4 (6.9-7.9)
Supplemental oxygen,a y 3.1 (2.8-3.4) < .001
No supplemental oxygen, y 8.3 (7.8-9.1)
Burkholderia cepacia complex, y 2.8 (2.4-3.9) < .001
No B cepacia complex, y 6.9 (6.4-7.3)
CFRD, on insulin, y 4.3 (3.7-4.7) < .001
No CFRD, y 7.4 (6.9-7.9)

See Table 1 and 3 legends for expansion of abbreviations.

a

Continuous or nocturnal supplemental oxygen.